CNBX Pharmaceuticals Inc (CNBX)

[jim992]

No charts or guessing can compare with the US and International Patents that are underway.

Those coupled with the fact that 2018 will be the first year that CNBX has been debt free and continually gaining financial and medical community support create a completely different scenario for the company than we have seen before.

Debt free, receiving biopsies from around the world, studies having 100% apoptosis success in all cancers and the near future holding a patented process for charging patients to have their physicians send in biopsies to be tested and in turn be prescribed a personalized CNBX treatment make 2018 the year that CNBX goes from startup to established.

$ 20 has been the conservative pps estimate. Once CNBX is on the big board, I think it will end up around $ 100 pps based on what GWPH is trading at as CNBX has a firmer hold in the medical community with better products.

Just my opinion, but I have studied it since 2014 and everything has gone as the company has forecasted. Not many MMJ companies can say that.

Take care, Jim